The goal of research in my laboratory is an understanding of the role of protein tyrosine kinases in cancer maintenance and growth. The emphasis of the research is evaluation of targets and compounds close to application in the clinic, with an emphasis on metastatic colorectal cancer. This focus utilizes cancer cell lines as well as tissue samples from patients, including correlative samples from ongoing clinical trials of novel therapeutic agents. Currently, we are studying the tyrosine kinase Src in tissue culture, murine colon cancer models, and patient samples, where we have established a role for Src in acquired chemotherapy resistance. Related work includes evaluation of the role of BRAF mutations in colon cancer biology, with a focus on developing rationale therapeutic combinations based on the unique biology of this subset of colorectal cancer.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.